LIVER CANCER
Clinical trials for LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new LIVER CANCER trials appear
Sign up with your email to follow new studies for LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows early promise against Hard-to-Treat cancers
Disease control TerminatedThis early-stage study tested a new drug called BI 765049, alone or combined with another drug (ezabenlimab), in 21 Asian adults with advanced solid tumors (stomach, colorectal, pancreatic, liver, head and neck, or lung cancer) that have a specific marker called B7-H6. The main g…
Matched conditions: LIVER CANCER
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New combo aims to control resistant liver cancer
Disease control TerminatedThis study tested whether adding an experimental drug (VIC-1911) to the standard drug lenvatinib could help people with liver cancer that no longer responds to lenvatinib alone. Only 5 people were enrolled before the study was stopped early. The goal was to see if the combination…
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Experimental immune cell therapy for liver cancer hits early roadblock
Disease control TerminatedThis early-stage trial tested a new type of immune cell therapy (ET140203 T cells) in 8 adults with advanced liver cancer that had not responded to other treatments. The therapy was designed to target a protein called AFP found on cancer cells. The study was terminated early, so …
Matched conditions: LIVER CANCER
Phase: PHASE1 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:13 UTC
-
New registry aims to sharpen liver tumor ablation techniques
Knowledge-focused TerminatedThis study tracked over 1,200 people with liver cancer who received microwave ablation, a procedure that uses heat to destroy tumors. Researchers collected data over 5 years to see how well the ablation worked and how long patients lived. The goal was to create better guidelines …
Matched conditions: LIVER CANCER
Sponsor: Ethicon, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC